(Q52274970)

28 April 2018

title

Prior morphine exposure enhances ibogaine antagonism of morphine-induced dopamine release in rats. (English)

1 reference

28 April 2018

1 reference

1 reference

Pearl SM

1

1 reference

28 April 2018

Maisonneuve IM

series ordinal

2

1 reference

28 April 2018

Glick SD

series ordinal

3

1 reference

28 April 2018

publication date

1 January 1996

1 reference

28 April 2018

published in

Neuropharmacology

1 reference

28 April 2018

volume

35

1 reference

28 April 2018

issue

12

1 reference

28 April 2018

page(s)

1779-1784

1 reference

28 April 2018

Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Inhibitory effects of ibogaine on cocaine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Ibogaine-like effects of noribogaine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Effects and aftereffects of ibogaine on morphine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Radioligand-binding study of noribogaine, a likely metabolite of ibogaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Ibogaine antagonizes cocaine-induced locomotor stimulation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2896%2900116-5

10.1016/S0028-3908(96)00116-5

7 January 2021

Identifiers

DOI

1 reference

28 April 2018

1 reference

28 April 2018